National-scale higi study finds spike in hypertension amid guidelines change
At the recent American Heart Association Hypertension 2018 Scientific Sessions, Chicago-based population health company higi presented its analysis on a nearly 30% increase in Americans classified as having high blood pressure in the aftermath of new AHA and American College of Cardiology guidelines.
The guidelines, handed down in early 2017, classified high blood pressure as a measurement of 130/80 mmHg, a change from the previous 140/80 mmHg guidelines. In examining nearly 40 million blood pressure tests across higi’s network of more than 11,000 retail pharmacy and community-based health stations in 2017, the company found a 28.8% increase in patients with high blood pressure. This nearly doubled the rate of blood pressure nationally to 62.4% from 33.6%, higi said.
More populated, urban areas in high-income communities saw the greatest increases, according to higi’s analysis, which also found that less populated, lower-income areas still had higher incidences of high blood pressure readings.
“High blood pressure readings are widely prevalent across all population centers, impacting a diverse subset of communities and cohorts,” said higi co-founder and chief medical officer Khan Siddiqui. “While blood pressure risk may still be greatest in disadvantaged populations, occurrence is spreading to include communities deemed more healthy and with higher incomes, making prioritization and risk stratification for providers and payers more challenging.”
The new blood pressure guidelines were implemented in May 2017 by higi, which said doing so allows consumers to see how their blood pressure measures up against the new standards, and receive information about next steps based on their degree of hypertension.
Jocko Willink to keynote ECRM VMS event
ECRM’s upcoming Vitamin, Weight Management and Sports Nutrition EPPS, set to kick off Sept. 30, will feature a keynote from retired Navy SEAL and best-selling author Jocko Willink. Willink, who also has a line of supplements, will give a talk titled “Combat Leadership: Build High Performance, Winning Teams.”
The focus of his ECRM keynote will be how retailers and suppliers can lead in dynamic situations, and will take place on Sept. 30, the first day of the event, which goes until Oct. 4 in Phoenix.
Willink’s talk will be based on his experience leading SEAL Team Three’s Unit Bruiser, which became the most highly decorated special operations unit of the Iraq war. A Silver Star and Bronze Star recipient, when Willink retired from the the Navy, he co-founded Echelon Front, a leadership consulting company. Willink’s leadership principles are the subject of his New York Times best-selling book, “Extreme Ownership: How U.S. Navy SEALs Lead and Win.” His latest book, “The Dichotomy of Leadership,” is co-authored with Leif Babin and is set to be released later this month.
Willink’s line of supplements for athletes will be showcased at the ECRM event. Products include Jocko Molk protein powder, Jocko discipline Force Multiplier pre-workout, Jocko Joint Warfare for anti-inflammation and Iced Jocko White Tea.
Eosera intros Ear Pain MD for adults, children
Ear care company Eosera is bringing two new products to market. The company recently announced the launch of Ear Pain MD and Ear Pain MD for Kids, both meant to topically relieve ear pain, a symptom commonly associated with ear infections.
“Ear Pain MD is different than other over-the-counter pain relievers because it is applied topically as opposed to orally. This allows the product to work faster and get to the actual site of the pain immediately,” said Eosera chief scientific officer and co-founder Joe Griffin. “It is always recommended to talk with your doctor first before using any product in the ear.”
Eosera noted that Ear Pain MD works by desensitizing aggravated nerves, providing numbing relief, but is not intended to address infection. It uses the maximum-strength relief without a prescription, the company said, noting that roughly 3 million patients seek ear infection treatment per year, and 83% of children experience the condition before their third birthday.
“The current standard of care for an ear infection diagnosis includes doctors typically prescribing antibiotics to treat the infection, and recommending oral pain relievers such as acetaminophen and ibuprofen, which can take up to an hour to work,” Eosera CEO and co-founder Elyse Dickerson said. “Our goal with the launch of Ear Pain MD is to provide more rapid pain relief that may be associated with ear infections and other ear-related issues.”
Ear Pain MD and the children’s variety join the company’s other product, Earwax MD. It’s currently sold at CVS Pharmacy and select Target stores, as well as on Amazon.com.